Author |
Year of Publication |
Type of Study |
Purpose of Study |
Intervention Studied |
Result/Conclusion |
Wings et al. [8] |
2019 |
Case-control study |
To determine if plasma cholesterol and genetic variants of various cholesterol transport proteins are associated with AD. |
Total cholesterol, LDL-C, HDL-C, TG, and genetic variants in ApoB, ApoE, APP, PSEN1 and PSEN2. |
Primary outcome: the relationship between plasma cholesterol and AD was seen. Secondary outcome: AD was associated with mutations in APOE, APP, PSEN1, PSEN2, and APOB. |
Jeong et al. [6] |
2019 |
Literature review |
To determine if APOE induced cholesterol dysfunction affects the various brain cells and causes AD. |
APOE4, APOE3, APOE2 alleles |
APOE ɛ4 one or more alleles increase the risk of AD |
Li et al. [48] |
2017 |
Case-control study |
To determine if the ABCA7 genotype of cholesterol transport protein it's associated with sporadic AD |
ABCA7 genotyping |
ABCA7 genotype was associated with lipid homeostasis and AD. |
Yassine et al. [16] |
2016 |
Cross-sectional study |
To determine if ABCA-1 mediated cholesterol efflux is affected in patients with AD and MCI |
CSF's role in cholesterol transport was assessed using a BHK cell line that expressed the ABCA1 transporter. |
In case of MCI and AD, the role of CSF was impaired. ABCA1‐mediated cholesterol efflux does not take place as normal, leading to AD. |
Agarwal et al. [45] |
2014 |
Meta-analysis |
To determine the association between ApoE alleles and the risk for AD |
APOE genotyping |
All genotypes of the ApoE e4 allele, increase the risk of AD, although the ApoE e2, e3 alleles protect from AD. |
Toro et al. [44] |
2014 |
Cohort study |
To determine the association of total cholesterol in AD and MCI and the ApoE genotype |
Total cholesterol |
High TC levels are associated with AD but are independent of the APOE genotype. |
Lukiw [49] |
2014 |
Literature review |
To determine if cholesterol and 24 hydroxycholesterol trafficking in the brain causes AD and CYP46A1 gene effects on AD |
Cholesterol and 24 hydroxycholesterol, beta-amyloid plaques, CYP46A1 genotyping |
Beta-amyloid plaques, which is characteristic of AD, were found with increased CSF 24 hydroxycholesterol, a mutation in the CYP46A1 gene causes dysfunctional cholesterol metabolism |
Caramelli et al. [47] |
1999 |
Case-control study |
To determine the relationship between plasma lipids and AD. |
VLDL, HDL-C, LDL-C, triglycerides, ApoB, lipoprotein (a) |
Significantly higher Apolipoprotein B levels were found in AD patients, whereas the concentration of lipoprotein (a) and plasma lipids was not statistically different. This shows that APOE may not be the only transporter associated with AD. |
Raygani et al. [46] |
2006 |
Case-control study |
To determine the association between plasma lipids, ApoE polymorphism, and with AD |
HDL-C, LDL-C, TC, APOB, APOE4, APOA1 |
Apolipoprotein e4 is associated with AD. Also, decreased ApoA1, HDL-C, increased ApoB, increased LDL-C, TC is seen in AD |
Panza et al. [10] |
2006 |
Literature review |
To determine the association between TC, 24 S hydroxycholesterol, LDL-C, Lp(A), ApoE levels with AD |
TC, 24S HC, LDL-C, Lp(A), APOE |
TC, LDL-C, Lp(A) was found to be elevated in patients with AD. No consistent association between ApoE and AD have been found in this study |
Martins et al. [5] |
2006 |
Literature review |
To understand cholesterol mechanism, the relation between APOE allele and AD, determine convergence risk factors for AD and CAD |
APOE ɛ4 allele |
APOE ɛ4 one or more alleles increase the risk of AD. A decrease in APO A1 is associated with AD. |
Kivipelto et al. [43] |
2002 |
Cohort study |
To determine the association between APOE ɛ4 allele and AD |
APOE genotype |
APOE ɛ4 alleles are associated with AD |